Newsroom

$1,000-per-pill drug overtaken by pricier successor

The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.

Read more

PRESS STATEMENT: New Report Shows Hepatitis C Drugs Have Costly Impact on California

Exorbitant price tags for specialty medications are taking a serious financial toll on state budgets. A new analysis released yesterday from the California Association of Health Plans (CAHP) shows that treating only 10 percent of 175,000 patients in state-funded health care programs with just three hepatitis C medications would cost California roughly $1-2 billion.

Read more

How new drugs helping millions of Americans live longer are also making them go broke

Around the U.S., people with serious diseases are falling through the cracks, unable to afford the medication they need. Patients with HIV, cancer, lupus, leukemia, hepatitis C and other serious conditions are paying huge out-of-pocket sums for necessary medication. These costs are putting heavy mental and financial stress on some of America’s most vulnerable people.

Read more

PwC Infographic: Costs from specialty drugs skyrocketing

A new PricewaterhouseCoopers report on medical cost trends highlights how specialty drugs are outpacing traditional drugs in a major way.

Read more